Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline

BACKGROUND: In March 2014, the American Heart Association updated their guidelines for the management of oral anticoagulation (OAC) in atrial fibrillation, recommending OAC for all patients with CHA (2) DS (2)‐VASc ≥2. Previously, only patients with CHADS (2) ≥2 were recommended for anticoagulation....

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Matthew P., Saba, Samir, Zhang, Yuting, Hernandez, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778974/
https://www.ncbi.nlm.nih.gov/pubmed/29301756
http://dx.doi.org/10.1161/JAHA.117.007881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778974/
https://www.ncbi.nlm.nih.gov/pubmed/29301756
http://dx.doi.org/10.1161/JAHA.117.007881

Ejemplares similares